Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 and Oxaliplatin vs S-1 and Cisplatin in Advanced Gastric Cancer (SOPP)
NCT01671449Phase 3Completed
- Start
- Dec 2012
- Primary completion
- Oct 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of oxaliplatin in gastric cancer (GC). Started Dec 2012; status: completed.
02
Drugs
oxaliplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01671449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01671449.